Evaluation of the prevalence of MASLD, MASH and liver fibrosis in a Dutch bariatric cohort.
<h4>Background and aims</h4>The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) in bariatric populations has been widely studied but may vary geographically. This study evaluates MASLD/MASH prevale...
Saved in:
| Main Authors: | Willy Theel, Willem-Pieter Brouwer, Elisabeth van Rossum, Jan Apers, Susan Ter Borg, Tessa Noordermeer, Manuel Castro Cabezas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0324813 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the prevalence of MASLD, MASH and liver fibrosis in a Dutch bariatric cohort
by: Willy Theel, et al.
Published: (2025-01-01) -
Pharmacotherapeutic perspectives on nutraceuticals in the treatment of MASLD and MASH
by: Ali H. Eid, et al.
Published: (2025-05-01) -
Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH
by: Thomas Zöggeler, et al.
Published: (2025-12-01) -
Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways
by: Shi-Long Wang, et al.
Published: (2025-07-01) -
Gaps in MASLD/MASH Education: A Quantitative and Qualitative Survey with Leaders of US Graduate Medical Education Programs
by: Allen AM, et al.
Published: (2025-05-01)